COPD

>

Latest News

Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPD / Image credit: ©Oleksandr/AdobeStock
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPD

September 6th 2024

In a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.

FDA Approves Ensifentrine for Maintenance Treatment of COPD in Adults: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves Ensifentrine for Maintenance Treatment of COPD in Adults: Daily Dose

July 8th 2024

FDA Decision on Dupilumab for COPD Pushed Back to September 2024
FDA Decision on Dupilumab for COPD Pushed Back to September 2024

May 31st 2024

Tezepelumab Found to Reduce Rate of COPD Exacerbations in Persons with Wide Range of Blood Eosinophil Levels: Daily Dose / image credit: ©New Africa/AdobeStock
Tezepelumab Found to Reduce Rate of COPD Exacerbations in Persons with Wide Range of Blood Eosinophil Levels: Daily Dose

May 28th 2024

Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes ©Crystal Light/stock.adobe.com
Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes

May 22nd 2024

More News

Malpositioned Nasogastric Tube

Malpositioned Nasogastric Tube

Luis Taylor, MD
May 1st 2003

A 67-year-old woman, who had hypertension and chronic obstructive pulmonary disease, presented to the emergency department with mild abdominal discomfort and shortness of breath.

Foreign Body

Foreign Body

April 1st 2003

A 40-year-old man presented to the emergency department with moderate to severe pain over the left lateral wrist. Earlier in the day, an iron rod had accidentally struck his wrist. The patient’s history included chronic obstructive pulmonary disease, hypertension, and social anxiety disorder.

<1
...
678910
© 2024 MJH Life Sciences

All rights reserved.